Literature DB >> 22023482

Rhabdomyolysis precipitated by a sitagliptin-atorvastatin drug interaction.

R Bhome, H Penn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22023482     DOI: 10.1111/j.1464-5491.2011.03502.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


× No keyword cloud information.
  5 in total

1.  Rhabdomyolysis and AKI with Atorvastatin and Sitagliptin Use in the Setting of Low 25-Hydroxyvitamin D Levels.

Authors:  Rupinder Singh Buttar; Jasveen Batra; Jacqueline Kreimerman; Melissa Aleta; Michal L Melamed
Journal:  J Gen Intern Med       Date:  2017-07-13       Impact factor: 5.128

Review 2.  Comparative clinical pharmacokinetics of dipeptidyl peptidase-4 inhibitors.

Authors:  Larry K Golightly; Caitlin C Drayna; Michael T McDermott
Journal:  Clin Pharmacokinet       Date:  2012-08-01       Impact factor: 6.447

3.  Effect of ABCB1 polymorphisms and atorvastatin on sitagliptin pharmacokinetics in healthy volunteers.

Authors:  Christina L Aquilante; Michael F Wempe; Maha S Sidhom; Lisa A Kosmiski; Julie A Predhomme
Journal:  Eur J Clin Pharmacol       Date:  2013-02-14       Impact factor: 2.953

4.  Case Report: Rhabdomyolysis secondary to vildagliptin overdose in a suicidal attempt: A case report and brief literature review.

Authors:  Zhijia Tang; Xiaofang Fan; Zhen Feng; Bing Han; Nan Guo
Journal:  Front Pharmacol       Date:  2022-08-10       Impact factor: 5.988

5.  Acute-onset rhabdomyolysis secondary to sitagliptin and atorvastatin interaction.

Authors:  Muhammad Waqas Khan; Saji Kurian; Rohit Bishnoi
Journal:  Int J Gen Med       Date:  2016-04-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.